These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2454772)
1. Expression of a C-reactive protein neoantigen (neo-CRP) in inflamed rabbit liver and muscle. Rees RF; Gewurz H; Siegel JN; Coon J; Potempa LA Clin Immunol Immunopathol; 1988 Jul; 48(1):95-107. PubMed ID: 2454772 [TBL] [Abstract][Full Text] [Related]
2. Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit. Potempa LA; Siegel JN; Fiedel BA; Potempa RT; Gewurz H Mol Immunol; 1987 May; 24(5):531-41. PubMed ID: 2443837 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity. Potempa LA; Zeller JM; Fiedel BA; Kinoshita CM; Gewurz H Inflammation; 1988 Aug; 12(4):391-405. PubMed ID: 2459061 [TBL] [Abstract][Full Text] [Related]
4. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP. Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575 [TBL] [Abstract][Full Text] [Related]
5. Preferential expression of neo-CRP epitopes on the surface of human peripheral blood lymphocytes. Samberg NL; Bray RA; Gewurz H; Landay AL; Potempa LA Cell Immunol; 1988 Oct; 116(1):86-98. PubMed ID: 2458846 [TBL] [Abstract][Full Text] [Related]
6. Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. Ying SC; Gewurz H; Kinoshita CM; Potempa LA; Siegel JN J Immunol; 1989 Jul; 143(1):221-8. PubMed ID: 2471736 [TBL] [Abstract][Full Text] [Related]
7. Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides. Ying SC; Shephard E; de Beer FC; Siegel JN; Harris D; Gewurz BE; Fridkin M; Gewurz H Mol Immunol; 1992 May; 29(5):677-87. PubMed ID: 1374844 [TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi: detection of a surface antigen cross-reactive to human C-reactive protein. Melo Coutinho CM; Cavalcanti GH; Bonaldo MC; Mortensen RF; Araújo-Jorge TC Exp Parasitol; 1998 Oct; 90(2):143-53. PubMed ID: 9769244 [TBL] [Abstract][Full Text] [Related]
9. A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury. Thiele JR; Zeller J; Kiefer J; Braig D; Kreuzaler S; Lenz Y; Potempa LA; Grahammer F; Huber TB; Huber-Lang M; Bannasch H; Stark GB; Peter K; Eisenhardt SU Front Immunol; 2018; 9():675. PubMed ID: 29713320 [TBL] [Abstract][Full Text] [Related]
10. Carbohydrate-binding properties of human neo-CRP and its relationship to phosphorylcholine-binding site. Lee RT; Lee YC Glycobiology; 2003 Jan; 13(1):11-21. PubMed ID: 12634320 [TBL] [Abstract][Full Text] [Related]
11. Preferential binding and aggregation of rabbit C-reactive protein with arginine-rich proteins. Dougherty TJ; Gewurz H; Siegel JN Mol Immunol; 1991 Oct; 28(10):1113-20. PubMed ID: 1922103 [TBL] [Abstract][Full Text] [Related]
12. Efficient preparation of monospecific anti-canine C-reactive protein serum and purification of canine C-reactive protein by affinity chromatography. Yamamoto S; Abe N; Santsuka H; Shida T; Kishida K; Kuwajima S; Yamada M; Morimatsu M; Naiki M Vet Immunol Immunopathol; 1993 Apr; 36(3):293-301. PubMed ID: 8506618 [TBL] [Abstract][Full Text] [Related]
13. Reactivity of anti-human C-reactive protein (CRP) and serum amyloid P component (SAP) monoclonal antibodies with limulin and pentraxins of other species. Ying SC; Marchalonis JJ; Gewurz AT; Siegel JN; Jiang H; Gewurz BE; Gewurz H Immunology; 1992 Jun; 76(2):324-30. PubMed ID: 1378818 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein: structure, function, regulation, and role in clinical diseases. Zhou HH; Tang YL; Xu TH; Cheng B Front Immunol; 2024; 15():1425168. PubMed ID: 38947332 [TBL] [Abstract][Full Text] [Related]
15. C-reactive protein and the acute phase response. Gewurz H; Mold C; Siegel J; Fiedel B Adv Intern Med; 1982; 27():345-72. PubMed ID: 7041546 [TBL] [Abstract][Full Text] [Related]
16. Development of monkey C-reactive protein (CRP) assay methods. Jinbo T; Hayashi S; Iguchi K; Shimizu M; Matsumoto T; Naiki M; Yamamoto S Vet Immunol Immunopathol; 1998 Feb; 61(2-4):195-202. PubMed ID: 9613434 [TBL] [Abstract][Full Text] [Related]
17. A synthetic peptide corresponding to the phosphorylcholine (PC)-binding region of human C-reactive protein possesses the TEPC-15 myeloma PC-idiotype. Swanson SJ; Lin BF; Mullenix MC; Mortensen RF J Immunol; 1991 Mar; 146(5):1596-601. PubMed ID: 1704398 [TBL] [Abstract][Full Text] [Related]
18. A hypothesis resolving the apparently disparate activities of native and altered forms of human C-reactive protein. Shields MJ Immunol Res; 1993; 12(1):37-47. PubMed ID: 8515183 [TBL] [Abstract][Full Text] [Related]
19. Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system. Jiang H; Lint TF; Gewurz H Immunology; 1991 Dec; 74(4):725-31. PubMed ID: 1783430 [TBL] [Abstract][Full Text] [Related]
20. Simple isolation of canine C-reactive protein (CRP) by phosphorylcholine (PC) affinity chromatography. Fujise H; Takanami H; Yamamoto M; Ohta I; Yamamoto S; Fukase T; Naiki M; Akihama S; Ogawa E; Takahashi R J Vet Med Sci; 1992 Feb; 54(1):165-7. PubMed ID: 1558881 [No Abstract] [Full Text] [Related] [Next] [New Search]